Wall Street Journal reporter Suzanne Oliver spotlights two MIT efforts to innovate the face mask. Prof. Giovanni Traverso and his colleagues are developing a reusable, silicon-rubber mask with “sensors that give feedback on fit and functionality,” while Prof. Michael Strano has designed a version that “incorporates a copper mesh heated to about 160 degrees that traps and deactivates the virus.”
Dr. Francis Collins, director of the NIH, spotlights Prof. Ed Boyden’s work developing a new technology that “enables researchers for the first time to study an intact tissue sample and track genetic activity on the spot within a cell’s tiniest recesses, or microenvironments—areas that have been largely out of reach until now.”
Smithsonian reporter Theresa Machemer writes that a new study by MIT researchers shows that C. elegans are able to sense and avoid the color blue.
A new study by MIT researchers investigates how roundworms are able to sense the color blue to avoid dangerous bacteria that secrete toxins, reports Veronique Greenwood for The New York Times. Greenwood found that “some roundworms respond clearly to that distinctive pigment, perceiving it — and fleeing from it — without the benefit of any known visual system.”
STAT reporter Alissa Ambrose spotlights the Koch Institute’s annual image awards, “which includes colorful images of micro needles, brain cells, and so-called mini livers.” Ambrose notes that the pictures are “stunning visualizations of life sciences and biomedical research being conducted to find treatments and cures for cancer.”
In an opinion piece for The Los Angeles Times, Institute Professor Phillip Sharp, Ellen Sigal of the Friends of Cancer Research and Sherry Lansing of the Sherry Lansing Foundation underscore the importance of selecting an effective leader for the FDA. “In order to restore trust in the FDA, and restore morale within, a permanent leader with expansive experience, medical expertise and the confidence of agency staff and the American public needs to be nominated in short order,” they write.
Professor Angelika Amon, an award-winning cell biologist and “an advocate for the kinds of studies that grind away outside of the limelight,” died on Oct. 29, reports Bryan Marquard for The Boston Globe. Amon’s daughter, Clara Weis, noted that Amon “was pretty much the best role model there is. She was very caring and understanding. She always knew what was happening and how to deal with it the right way.”
Times Higher Ed reporter Matthew Reisz memorializes the life and work of Prof. Angelika Amon, a “trailblazing” scientist known for her research into the life cycle of cells. “Angelika existed in a league of her own,” says Whitehead fellow Kristin Knouse. “She had the energy and excitement of someone who picked up a pipette for the first time, but the brilliance and wisdom of someone who had been doing it for decades.”
The Association for the Advancement of Artificial Intelligence has awarded Prof. Regina Barzilay a $1 million prize for her work advancing the use of AI in medicine, reports John McCormick for The Wall Street Journal. "Regina is brilliant, has very high standards, and is committed to helping others,” says Prof. James Collins. “And I think her experience with—her personal experience with cancer—has motivated her to apply her intellectual talents to using AI to advance health care.”
The AP highlights how Prof. Regina Barzilay has been named the inaugural winner of a new award given by the Association for the Advancement of Artificial Intelligence for her work “using computer science to detect cancer and discover new drugs has won a new $1 million award for artificial intelligence.”
Prof. Regina Barzilay has been named the inaugural recipient of the Squirrel AI Award for Artificial Intelligence to Benefit Humanity for her work developing new AI techniques to help improve health care, reports Rebecca Robbins for STAT. Robbins writes that Barzilay is focused on turning the “abundance of research on AI in health care into tools that can improve care.”
MIT researchers have created a new synthetic lining that could be used to help treat digestive diseases, reports Pratibha Gopalakrishna for STAT. “We wanted to develop a liquid system that is easier to take compared to tablets or capsules, but had enhanced capabilities,” explains Prof. Giovanni Traverso.
New Scientist reporter Alice Klein writes that MIT researchers have developed a synthetic glue that could be used to line the small intestine and help treat several conditions, including diabetes and lactose intolerance. “The researchers found they could control the uptake of different nutrients,” writes Klein, “by adding various substances to the synthetic lining.”
MIT researchers outfitted a Boston Dynamics robotic dog with contactless vital sign monitoring equipment to help clinicians care for patients with Covid-19 without risking exposure, reports Darrell Etherington for TechCrunch. Etherington writes that the system “has the potential to not only reduce the risk of exposure for medical personnel, but also drastically reduce use of personal protective equipment.”
Reporting for CNN, Scottie Andrew highlights how researchers from MIT and Brigham and Women’s Hospital developed the iMASC, a silicon mask that can be reused and sterilized multiple times. Andrew notes that the mask is “a promising step toward addressing the critical healthcare supply shortages.”